Delia Gratta

Rani Therapeutics (United States)

Papers

1

Total Citations

94

H-Index

1

About

Delia Gratta is a pioneering biomedical engineer whose research centers on the development of advanced oral drug delivery systems, with a particular focus on robotic platforms for biotherapeutics. Her most impactful contribution is the design and clinical validation of a novel robotic pill that enables the oral delivery of large-molecule drugs—a long-standing challenge in pharmaceutical science. In her landmark 2021 study, cited over 90 times, Gratta demonstrated the safety, tolerability, and performance of this device in healthy subjects, offering a transformative alternative to chronic injections. This work directly addresses the critical issue of patient non-compliance caused by the pain and inconvenience of injectable therapies. By engineering a device that protects biotherapeutics from degradation in the gastrointestinal tract, Gratta has opened new avenues for managing chronic diseases more comfortably and effectively. Her research bridges mechanical engineering, materials science, and clinical medicine, positioning her as a leading figure in the quest to replace needles with smart, ingestible technologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects
94 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Rani Therapeutics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago